Purchase Order HHSN272201600108P
Award Date
11/17/15
Potential Completion Date
4/9/16
Potential Value
$5.9K
Federal Agency
NIAID DEA OA Acquisitions
Awardee
Ozgene PTY LTD
Ultimate Awardee
Not listed
NAICS Category
112990 - All Other Animal Production
PSC Category
8820 - Live Animals, Not Raised For Food
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Australia
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services' National Institutes of Health (NIH), is for Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services for biomedical research. The $70,800.00 firm-fixed-price delivery order is for the exercise of Option Year II of a previous contract, HHSN272200900005I, to provide conditional knockout/knock-in...
This contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services' National Institutes of Health (NIH), to Ozgene Pty Ltd, an Australian company. The contract, valued at $67,700.00, is for the provision of genetically modified mice and rats to support biomedical research. The contract does not have a set-aside designation. Ozgene, the prime contractor, will provide gene targeting vectors, mouse backcrossing,...
This federal contract award to Ozgene PTY LTD, an Australian company, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH) under the U.S. Department of Health and Human Services. The $65,800 firm fixed-price delivery order is for the provision of genetically modified mouse strains to support biomedical research. Ozgene, the prime contractor, specializes in gene targeting, knockout, and knock-in mouse models....
This federal contract award is for Task Order 19 under a broader Delivery Order contract with Ozgene PTY LTD, an Australian company providing genetically modified mice and related services in support of biomedical research. The $67,700.00 firm fixed price contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The contract provides for services such as...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Ozgene Pty Ltd, an Australian company that provides genetically modified mice and related services to support biomedical research. The $17,298.00 firm fixed-price delivery order is for additional breeding services for genetically modified knock-in and knock-out mice, which are used to study various diseases and disorders such as...
This federal contract award, valued at $50,600.00, was issued by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to the prime contractor Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The contract is for the provision of live animals, not raised for food, and does not have a set-aside designation. Ozgene has previously received other federal contract awards...
This federal contract award, identified as HHSN272200900005I|HHSN27200015, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services' National Institutes of Health (NIH), to the prime contractor Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The $7,286.00 Firm Fixed Price contract is for the delivery of additional breeding and mouse...
This federal contract award is for the provision of live animals, specifically genetically modified mice, to support biomedical research. The prime contractor, Ozgene PTY LTD, an Australian company, is providing gene targeting vectors, mouse backcrossing, and the creation of gene knockout and gene knock-in mice to various agencies within the U.S. Department of Health and Human Service's National Institutes of Health (NIH). The contract, with a ceiling value of $5,971.00, is a firm fixed-price...
This federal contract award to Ozgene PTY LTD, an Australian company, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services' National Institutes of Health (NIH). The $7,286.00 firm fixed-price delivery order contract supports additional breeding and other services related to the development of genetically modified mice for biomedical research. Ozgene, the prime contractor, provides gene targeting vectors, mouse...
This federal contract award, with an ID of HHSN272200900005I|HHSN27200024, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the U.S. Department of Health and Human Services' National Institutes of Health (NIH). The prime contractor is Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The contract, which has a ceiling value of $2,024.00, is a delivery order for gene...